| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |